|
Volumn 102, Issue 6, 2005, Pages 408-410
|
Has the Swedish Medical Products Agency left evidence-based medicine behind? Ban on SSRI for children and adolescents is unfounded;Har Läkemedelsverket lämnat den evidensbaserade medicinen? Bannlysningen av SSRI till barn och ungdomar vilar på lösan grund
c
Läkemedelsverket
*
(Sweden)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SEROTONIN UPTAKE INHIBITOR;
DRUG INDUSTRY;
EVIDENCE BASED MEDICINE;
HUMAN;
NEGATIVE FEEDBACK;
POSTMARKETING SURVEILLANCE;
SHORT SURVEY;
SWEDEN;
ADOLESCENT;
CHILD;
DEPRESSIVE DISORDER;
EVIDENCE-BASED MEDICINE;
HUMANS;
PRACTICE GUIDELINES;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
SUICIDE;
|
EID: 13844277053
PISSN: 00237205
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (0)
|